GSK

China Biotech Week in Review: GSK Acquires Urology Drugmaker	Clinical Data: Highly Anticipated FDA Decision Could Revive Interest	Glaxo Goes on an Acquisition Spree
GlaxoSmithKline: An Atypical Dividend Investment	Ramius’ Persistence Pays Off: Cypress Biosciences Finally Says Yes - Biotech's Latest M&A Action	The Winner of ASH 2010: Seattle Genetics
India Markets Wednesday Wrap-Up: Negative Close as Banks Continue Slide	6 High Yield Pharmaceutical Companies: Do they Justify the Risk?	Top 19 Most Profitable Large Cap Stocks
20 Underperforming Stocks With a Track Record of Profitability	Life Sciences Deal Flows Boost Positive Mood at JPMorgan Healthcare Conference	Wall Street Breakfast: Must-Know News
Biotech Merger/Acquisition Activity Mixed During Major Conference	Glaxo's Latest $3.4 Billion Charge Over Avandia Reveals Costs of Misbehavior	GlaxoSmithKline: Latest Legal Charge Proves Very Costly
GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations	Friday Options Recap	Arena Pharma Slashes Workforce by 25 Percent: Biotech's Latest Tribulations
GlaxoSmithKline PLC (ADR) CEO Discusses Q4 2010 Results - Earnings Call Transcript	15 British Stocks to Raise Dividend Payouts in 2011	Value Pharma Stocks in Overpriced Market
Jury Nails J&J With $482 Million Patent Infringement Verdict: Biotech's Latest Tribulations	A Look at Warren Buffett's 5 Highest Yielding Stock Holdings	Mannkind Slashes Staff: Biotech's Latest Tribulations

Main menu